Skip to main content
SpringerLink
Log in

An overview of the Greek pharmaceutical market

  • Pricing and Reimbursement
  • Published:
The European Journal of Health Economics, formerly: HEPAC Aims and scope Submit manuscript

Abstract

This contribution presents the major aspects of the pharmaceutical market in Greece. Total expenditure on pharmaceuticals rose from €1.22 billion in 1995 to €1.85 billion in 2000. The rise in pharmaceutical expenditure is expected to continue due to factors determining demand (e.g., aging population) and deficiencies in public policy. The latter is related to the pricing and reimbursement of medicinal products. Regarding pricing, the lowest ex-factory price in the EU is applied de facto to imported products but for domestically produced/packaged products is the upper limit. The pharmaceutical market in Greece has a trade deficit, which exceeded €953 million in 2000. Finally, parallel trade has received increased attention. The consequences are twofold: shortages in Greek pharmacies and delays in launching new and more effective drugs. The latter is the result of a defensive strategy followed by major companies to minimize the effects of this activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Souliotis K, Kyriopoulos J (2002) Trends in the pharmaceutical market in Greece. Primary Health Care 13:10–16

    Google Scholar 

  2. Kontozamanis V (2000) Prices, consumption & expenditure in the Greek pharmaceutical market. Athens: FEIR

  3. Geitona M, Kyriopoulos J (1999) The economics and politics of pharmaceuticals in Greece. Athens: Themelio

  4. Souliotis K, Kyriopoulos J (2002) Health expenditure in Greece: methodological issues in the measurement and consequences for health policy. Athens: Papazisis

  5. IFET (2000) Sales data of medicinal products. Athens: IFET

  6. Kontozamanis V (2001) The Greek pharmaceutical market. Athens: FEIR

  7. Mossialos E, Kanavos P (1994) Policy options for pharmaceuticals in the European Union. London: London School of Economics

  8. FEIR (2002) EU harmonised survey on business investments: results. Athens: FEIR

  9. Jacobzone S (2000) Pharmaceutical policies in OECD countries: reconciling social and industrial goals. Labour Market and Social Policy, occasional paper no 40. Paris: OECD

  10. Lichtenberg F (1998) Pharmaceutical innovation, mortality reduction and economic gain. National Bureau of Economic Research, Cambridge

  11. Center for Health Services Management and Evaluation (2001) Expenditure on pharmaceuticals and the organizational and operational framework of pharmacies in greece and the EU. Athens: National and Kapodistrian University of Athens

  12. European Federation of Pharmaceutical Industries and Associations (2002) The pharmaceutical industry in figures. Brussels: European Federation of Pharmaceutical Industries and Associations

Download references

Author information

Authors and Affiliations

  1. Foundation of Economic and Industrial Research, Athens, Greece

    V. Kontozamanis & E. Mantzouneas

  2. Department of Economic and Regional Development, Panteion University, Athens, Greece

    C. Stoforos

  3. Foundation of Economic and Industrial Research, 11 Tsami Karatassi Str., 11742, Athens, Greece

    V. Kontozamanis

Authors
  1. V. Kontozamanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Mantzouneas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Stoforos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Kontozamanis.

Additional information

V. Kontozamanis, E. Mantzouneas, and C. Stoforos contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kontozamanis, V., Mantzouneas, E. & Stoforos, C. An overview of the Greek pharmaceutical market. HEPAC 4, 327–333 (2003). https://doi.org/10.1007/s10198-003-0206-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-003-0206-1

Keywords

Search

Navigation